Cover Image

全球血管內動脈瘤修復 (EVAR) 市場

Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition

出版商 Koncept Analytics 商品編碼 349911
出版日期 內容資訊 英文 52 Pages
Back to Top
全球血管內動脈瘤修復 (EVAR) 市場 Global Endovascular Aneurysm Repair (EVAR) Market Report: 2015 Edition
出版日期: 2016年01月15日 內容資訊: 英文 52 Pages

全球血管內動脈瘤修復 (EVAR) 市場,由於老年人口的增加、醫療相關支出的上升、腹部主動脈血管瘤 (AAA) 篩檢數量的增加,今後數年有市場成長可能性。

本報告提供全球血管內動脈瘤修復 (EVAR) 市場相關調查分析,市場規模 (數量·金額) ,加上主要趨勢,成長推動因素與課題,主要企業簡介等系統性資訊。

第1章 腹部主動脈血管瘤 (AAA)

  • 概要
  • 全球市場分析
  • 地區市場分析

第2章 血管內動脈瘤修復 (EVAR)

  • 概要
  • 全球市場分析
  • 地區市場分析

第3章 市場動態

  • 成長推動因素
  • 主要趨勢與發展
  • 課題

第4章 競爭情形

  • 競爭概要
  • 市場佔有率
  • 市場機會
  • 競爭企業比較

第5章 企業簡介

  • 產業概要、財務概要、產業策略
    • Medtronic Inc. (Endurant)
    • TriVascular (Ovation Xi)
    • Lombard Medical (Aorfix)



An abdominal aortic aneurysm (AAA) is a localized bulging or abnormal enlargement of the abdominal aorta (the largest artery in the human body), most often the infrarenal and aorto-iliac arteries. AAAs occur most often in Caucasian males over the age of 65 years; they are less common in women.

Endovascular aneurysm repair (EVAR) is a minimally invasive alternative to major open surgery for the repair of AAA's that results in reduced recovery times and potentially improved survival rates. It is a type of endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). Endovascular procedures aim to reduce the morbidity and mortality of treating arterial disease in a patient population that is increasingly older and less fit than when major open repairs were developed and popularized.

Growing numbers of geriatric population and associated expenditure for health care, steadily increasing cases of AAA screening worldwide are likely to fuel growth over the coming years. Postoperative complications like Endoleaks and migration is the biggest challenge faced by the industry. Also the growing number of regulations posed by regulatory authorities like FDA restricts the industry players. Some of the trends impacting the market include ongoing clinical studies, growing use of percutaneous EVAR, preferences for various AAA repair methods, and technological developments.

This report assesses the global EVAR market in terms of both market volume and market value on the global and regional level. The increasing competition in the EVAR industry has been analyzed on a variety of factors: revenue, surgical outcomes, postoperative procedures and complications. The top three companies having a vicious competition with each other and dominating the EVAR industry are- Medtronic, TriVascular and Lombard Medical. These players are being profiled in the report along with their key financials and strategies for growth.

Table of Contents

1. Abdominal Aortic Aneurysm (AAA)

  • 1.1. Overview
    • 1.1.1. Signs & Symptoms
    • 1.1.2. Diagnosis
    • 1.1.3. Management
  • 1.2. Global Market Analysis
    • Market Penetration
    • Market Segmentation
  • 1.3. Regional Market Comparison
    • 1.3.1. On the Basis of Diagnosed Cases & Procedures Performed
      • United States
      • Europe
    • 1.3.2. On the Basis of Prevalence by Gender
      • United States
      • Europe
    • 1.3.3. On the Basis of Prevalence by Population
      • United States
      • Europe
    • 1.3.4. On the Basis of Procedure Mix
      • United States
      • Europe

2. Endovascular Aneurysm Repair (EVAR)

  • 2.1. Overview
    • 2.1.1. Medical Applications
    • 2.1.2. Adjunctive Procedures
    • 2.1.3. Techniques
    • 2.1.4. Complications
  • 2.2. Global Market Analysis
    • Market Value (Actual & Forecasted)
    • Regional Breakdown (Actual & Forecasted)
    • Price Trend of Market Segments
  • 2.3. Regional Markets
    • 2.3.1. The US
      • Market Value
      • Procedure Share
    • 2.3.2. Europe
      • Market Value
      • Procedure Share
    • 2.3.3. Rest of the World
      • Market Value
      • Procedure Share

3. Market Dynamics

  • 3.1. Growth Drivers
    • 3.1.1. Ageing Population
    • 3.1.2. Increased AAA screening
    • 3.1.3. Suitability with Age Groups
    • 3.2.4. Rising Healthcare Expenditure
  • 3.2. Key Trends and Developments
    • 3.2.1. Clinical Studies & Publications
    • 3.2.2. Growing Adoption for PEVAR
    • 3.2.3. Procedural Characteristics
    • 3.2.4. Technological Developments
  • 3.3. Challenges
    • 3.3.1. Rising Chances of Endoleaks
    • 3.3.2. Stringent Regulations

4. Competitive Landscape

  • Competitive Overview
  • Market Share
  • Market Opportunity
  • Competitor Comparison

5. Company Profiles

  • 5.1. Medtronic Inc. (Endurant)
    • 5.1.1. Business Overview
    • 5.1.2. Financial Overview
    • 5.1.3. Business Strategies
  • 5.2. TriVascular (Ovation Xi)
    • 5.2.1. Business Overview
    • 5.2.2. Financial Overview
    • 5.2.3. Business Strategies
  • 5.3. Lombard Medical (Aorfix)
    • 5.3.1. Business Overview
    • 5.3.2. Financial Overview
    • 5.3.3. Business Strategies

List of Charts

  • AAA Market by Penetration (2015)
  • AAA Market Segmentation by Patient Anatomy (2014)
  • The US AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
  • European AAA Market by Number of Diagnosed Cases & Procedures Performed (2014-2020E)
  • The US AAA Prevalence Model by Gender (2014-2020E)
  • European AAA Prevalence Model by Gender (2014-2020E)
  • The US AAA Prevalence Model by Population (2014-2020E)
  • European AAA Prevalence Model by Population (2014-2020E)
  • The US AAA Market by Procedure Mix (2014-2020E)
  • European AAA Market by Procedure Mix (2014-2020E)
  • Global EVAR Market by Value - Actual (2010-2015E)
  • Global EVAR Market by Value - Forecast (2016F-2020F)
  • Global EVAR Market by Region - Actual (2010-2015E)
  • Global EVAR Market by Region - Forecast (2016F-2020F)
  • Regional EVAR Market Value YoY Change (2011-2020F)
  • Regional EVAR Market Segment by Average Selling Price (2014-2020E)
  • The US EVAR Market by Value (2014-2020E)
  • The US EVAR Market by Procedure Mix (2014-2020E)
  • European EVAR Market by Value (2014-2020E)
  • European EVAR Market by Procedure Mix (2014-2020E)
  • EVAR Market by Value, ROW (2014-2020E) Figure 2.12: EVAR Market by Procedure Mix, ROW (2015E)
  • Global Ageing Population (2009-2014)
  • Suitability of Endovascular Repair with Current Stent Grafts for AAA in Korean patients (2015)
  • Global Healthcare Expenditure (2007-2014)
  • EVAR Articles in the Vascular Surgery based Publications (1990-2014E)
  • PEVAR Market Share in the Total EVAR Procedures (2014-2016)
  • PEVAR Market Opportunity
  • On the basis of Procedural Preference
  • Secondary Interventions after EVAR (2014)
  • Prevalence of Endoleaks & Rates of Intervention
  • EVAR Device Mix Market Opportunity (2015-2020)
  • EVAR Device Market Share by Manufacturer (2015)
  • Competition on Basis of Minimum Post Procedural Complications
  • Medtronic Sales by Business Segment (FY2015)
  • Medtronic's Net Sales and Net Income (2011-2015)
  • TriVascular Sales by Region (2014-2015)
  • TriVascular Sales and Net Loss (2012-2018E)
  • Lombard Sales by Region (2014)
  • Lombard Sales and Net Loss (2012-2018E)

List of Tables

  • Prevalence of AAA 3.0 cm or larger in the age group 50-79 years
  • On The Basis of Patient Characteristics
  • On the basis of Surgical Outcomes, Postoperative Outcome & Complications
  • AAA Devices Market
  • ELGX Nellix vs. MDT's Endurant and WL Gore's Excluder Grafts Comparison
  • Factors Driving & Preventing Adoption of New EVAR Devices
Back to Top